You can buy or sell RARE and other stocks, options, ETFs, and crypto commission-free!
Ultragenyx Pharmaceutical Inc. Common Stock, also called Ultragenyx Pharmaceutical, is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Read More Its product includes Mepsevii and Crysvita. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.
52 Week High
52 Week Low
The Motley FoolMay 7
Ultragenyx Pharmaceutical Inc (RARE) Q1 2019 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Q1 2019 Earnings Call , 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon. My name is Jerome, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ultragenyx First Quarter 2019 Financial Results and Corporate Update. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-a...
Expected Aug 1, After Hours